Buy Recommendation Issued On CL By UBS
UBS analyst issues BUY recommendation for CL on May 4, 2026 01:31PM ET. The previous analyst recommendation was Buy.CL was trading at $85.96 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for CL on May 4, 2026 01:31PM ET. The previous analyst recommendation was Buy.CL was trading at $85.96 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues SECTOR PERFORM recommendation for CPT on May 4, 2026 01:23PM ET. The previous analyst recommendation was Sector Perform.CPT was trading at $105.1 at issue of the...
UBS analyst issues NEUTRAL recommendation for CHD on May 4, 2026 01:31PM ET. The previous analyst recommendation was Neutral.CHD was trading at $93.92 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for CHD on May 4, 2026 01:21PM ET. The previous analyst recommendation was Outperform.CHD was trading at $93.68 at issue of the analyst recommendation.The...
RBC Capital analyst issues SECTOR PERFORM recommendation for HUN on May 4, 2026 01:20PM ET. The previous analyst recommendation was Sector Perform.HUN was trading at $14.27 at issue of the...
Scotiabank analyst issues SECTOR PERFORM recommendation for LNT on May 4, 2026 01:17PM ET. The previous analyst recommendation was Sector Perform.LNT was trading at $73.57 at issue of the analyst...
UBS analyst issues NEUTRAL recommendation for MRNA on May 4, 2026 01:36PM ET. The previous analyst recommendation was Neutral.MRNA was trading at $47.05 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for NWL on May 4, 2026 01:33PM ET. The previous analyst recommendation was Neutral.NWL was trading at $4.6063 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for RNR on May 4, 2026 01:37PM ET. The previous analyst recommendation was Neutral.RNR was trading at $300.39 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for XOM on May 4, 2026 01:35PM ET. The previous analyst recommendation was Buy.XOM was trading at $151.7 at issue of the analyst recommendation.The overall...